OCT 09, 2018 04:19 PM PDT

'Copper Antibiotic Peptide' Effective in Eradicating Tuberculosis

WRITTEN BY: Nouran Amin

"Mycobacterium: the bacteria responsible for Tuberculosis", Image via National Institute of Health

The bacterium responsible for Tuberculosis has found a way to avoid antibiotics by hiding inside the macrophages which are the specific immune cells that are supposed to kill them, making treatment a challenge. However, a recent study published in ACS Infectious Diseases report a new antibiotic that can find and kill the tuberculosis bacteria exactly where they hide.

As the number one cause of death in infectious diseases worldwide, Tuberculosis infects about 25 percent of the people on the planet with most of these infections staying dormant. However, 1 in 10 infections do become active which is a fatality if left untreated.

Tuberculosis is a result of the bacterium Mycobacterium tuberculosis. Those infected with the bacterium often take a cocktail of antibiotics over the course of months in order to treat the resistant characteristics of the mycobacterium. Now, chemists at the University of Connecticut (UConn) along with colleagues from the Indian Institute of Science, the Max Planck Institute, and MIT, worked on an antibiotic that could make its way into the macrophages in order to target the Mycobacterium.

The UConn chemist Alfredo Angeles-Boza and then-graduate student, Daben Libardo, previously worked on an antibiotic derived from fish, sea squirts, and other sea creatures. These sea creatures, at least most of them, produce antibiotic peptides which are small pieces of protein-like material that are associated with an electrical charge. Copper, for example, possess the electrical charge ability that can become violent by ripping electrons away from some molecules like oxygen-containing molecules. Fortunately, since Mycobacteria contains oxygen it will be attacked by copper antibiotic peptide—completely eradicating it.

Image via theconversation.com

Surprisingly, human macrophages actually contain their very own copper that, when infected with Mycobacteria, will attack—however, they do so in a less sophisticated way. More specifically, the macrophage will enclose bacteria in a bubble and then inject copper +1 ions – which are plain copper atoms with a plus one charge (Cu+) – inside the bubble. However, the bubble method is no threat to the Mycobacterium and can handle it.

But, using the copper antibiotic peptide into smaller bubbles, the mycobacteria cannot withstand because the copper is close to the bacterium as opposed to being farther in the human macrophage bubble method.

The researchers hope to use this study and build on the chemistry to effectively make smaller molecules that can be packaged inside pills and taken like more typical antibiotics.

Source: ACS Infectious Diseases, Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 17, 2018
Drug Discovery
JUL 17, 2018
First Drug for Smallpox Treatment
TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox, was just approved by the U.S. Food and Drug Administration to SIGA Techno...
SEP 02, 2018
Genetics & Genomics
SEP 02, 2018
Insights From the Opium Poppy Genome
By sequencing the opium poppy's DNA, scientists have revealed important details about how it makes its medicine....
SEP 18, 2018
Drug Discovery
SEP 18, 2018
More Challenges in Immunotherapeutic Developments
Fighting disease using the immune system is the body’s most prized possession and it does so by utilizing immunotherapy. However, a discovery by rese...
OCT 01, 2018
Cell & Molecular Biology
OCT 01, 2018
Revealing How Antibiotics Work Against Bacteria
In a first, researchers have directly observed an antibiotic in action as it disrupted the membrane of a bacterial cell....
OCT 16, 2018
Drug Discovery
OCT 16, 2018
Anti-Venomous Plant Compound
According to a study published in PLOS Neglected Tropical Diseases, researchers at the Institute Butantan, São Paulo, Brazil, have discovered a flav...
OCT 24, 2018
Drug Discovery
OCT 24, 2018
Peptide Ruptures Viral Membrane of Zika Virus
According to a recent study at Nanyang Technological University, Singapore (NTU Singapore), a newly engineered antiviral peptide will aim to attack the vir...
Loading Comments...